Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Light Sciences Oncology Inc.

Headquarters: Bellevue, WA, United States of America
Year Founded: 2005
Status: Private

BioCentury | Mar 18, 2010
Distillery Therapeutics

Indication: Cancer

BioCentury | Aug 24, 2009
Clinical News

Aptocine talaporfin sodium: Phase II started

BioCentury | Aug 17, 2009
Clinical News

Aptocine talaporfin sodium: Phase I started

BioCentury | Dec 8, 2008
Clinical News

Litx: Completed Phase III enrollment

BioCentury | Jul 14, 2008
Clinical News

Litx: Phase I/II start

BioCentury | Jul 14, 2008
Clinical News

Litx: Phase IIa start

BioCentury | Apr 14, 2008
Company News

Light Sciences Oncology board of directors update

BioCentury | Jul 23, 2007
Clinical News

Litx: Phase III started

BioCentury | Feb 19, 2007
Clinical News

Litx: Phase II started

Items per page:
1 - 10 of 13